Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biased Signaling of the Mu Opioid Receptor Revealed in Native Neurons
Aliza T. Ehrlich, Meriem Semache, Florence Gross, et al.
iScience (2019) Vol. 14, pp. 47-57
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

G protein-coupled receptors: structure- and function-based drug discovery
Dehua Yang, Qingtong Zhou, Viktorija Labroska, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 425
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists
Alexander Gillis, Arisbel B. Gondin, Andrea Kliewer, et al.
Science Signaling (2020) Vol. 13, Iss. 625
Open Access | Times Cited: 314
Profiling the proximal proteome of the activated μ-opioid receptor
Benjamin J. Polacco, Braden T. Lobingier, Emily E. Blythe, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 9, pp. 1133-1143
Closed Access | Times Cited: 17
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor
Alexander Gillis, Andrea Kliewer, Eamonn Kelly, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 12, pp. 947-959
Open Access | Times Cited: 122
Biased ligands at opioid receptors: Current status and future directions
Tao Che, Hemlata Dwivedi‐Agnihotri, Arun K. Shukla, et al.
Science Signaling (2021) Vol. 14, Iss. 677
Open Access | Times Cited: 86
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists
Elise Wouters, Jolien Walraed, Samuel D. Banister, et al.
Biochemical Pharmacology (2019) Vol. 169, pp. 113623-113623
Closed Access | Times Cited: 79
Arrestin-Dependent and -Independent Internalization of G Protein–Coupled Receptors: Methods, Mechanisms, and Implications on Cell Signaling
Ee Von Moo, Jeffrey R. van Senten, Hans Bräuner‐Osborne, et al.
Molecular Pharmacology (2021) Vol. 99, Iss. 4, pp. 242-255
Open Access | Times Cited: 73
Molecular insights into the biased signaling mechanism of the μ-opioid receptor
Xiaojing Cong, Damien Maurel, Hélène Déméné, et al.
Molecular Cell (2021) Vol. 81, Iss. 20, pp. 4165-4175.e6
Open Access | Times Cited: 60
Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects
Ram Kandasamy, Todd M. Hillhouse, Kathryn E. Livingston, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 16
Open Access | Times Cited: 56
Biased Agonism: Lessons from Studies of Opioid Receptor Agonists
Eamonn Kelly, Alexandra E. Conibear, Graeme Henderson
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 491-515
Open Access | Times Cited: 47
The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models
Lola Welsch, Julie Bailly, Emmanuel Darcq, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 1, pp. 54-63
Open Access | Times Cited: 68
Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window
Alexander Gillis, Varun Sreenivasan, MacDonald J. Christie
Molecular Pharmacology (2020) Vol. 98, Iss. 4, pp. 410-424
Open Access | Times Cited: 62
Mu opioid receptor in microglia contributes to morphine analgesic tolerance, hyperalgesia, and withdrawal in mice
David J. Reiss, Tando Maduna, Hervé Maurin, et al.
Journal of Neuroscience Research (2020) Vol. 100, Iss. 1, pp. 203-219
Open Access | Times Cited: 50
Low Intrinsic Efficacy Alone Cannot Explain the Improved Side Effect Profiles of New Opioid Agonists
Edward L. Stahl, Laura Bohn
Biochemistry (2021) Vol. 61, Iss. 18, pp. 1923-1935
Open Access | Times Cited: 43
Illuminating the complexity of GPCR pathway selectivity – advances in biosensor development
Shane C. Wright, Michel Bouvier
Current Opinion in Structural Biology (2021) Vol. 69, pp. 142-149
Closed Access | Times Cited: 41
Neuropeptide System Regulation of Prefrontal Cortex Circuitry: Implications for Neuropsychiatric Disorders
Sanne M. Casello, Rodolfo J. Flores, Héctor E. Yarur, et al.
Frontiers in Neural Circuits (2022) Vol. 16
Open Access | Times Cited: 35
Selective targeting of mu opioid receptors to primary cilia
Rita R. Fagan, David F. Lee, Matan Geron, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114164-114164
Open Access | Times Cited: 6
Dissecting the roles of GRK2 and GRK3 in μ-opioid receptor internalization and β-arrestin2 recruitment using CRISPR/Cas9-edited HEK293 cells
Thor C. Møller, Mie Fabricius Pedersen, Jeffrey R. van Senten, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 47
Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform
Lakshmi Vasudevan, Marthe M. Vandeputte, Marie H. Deventer, et al.
Biochemical Pharmacology (2020) Vol. 177, pp. 113910-113910
Open Access | Times Cited: 45
Strategies for DevelopingκOpioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects
Kelly F. Paton, Diana Vivian Atigari, Sophia Kaska, et al.
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 375, Iss. 2, pp. 332-348
Open Access | Times Cited: 45
Increased mu-opioid receptor expression is associated with reduced disease-free and overall survival in laryngeal squamous cell carcinoma
Hao Zhang, Minli Sun, Di Zhou, et al.
British Journal of Anaesthesia (2020) Vol. 125, Iss. 5, pp. 722-729
Open Access | Times Cited: 34
Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation
Flaminia Coluzzi, Laura Rullo, Maria Sole Scerpa, et al.
CNS Drugs (2022) Vol. 36, Iss. 6, pp. 617-632
Open Access | Times Cited: 20
Functional expression of opioid receptors and other human GPCRs in yeast engineered to produce human sterols
Björn D. M. Bean, Colleen J. Mulvihill, Riddhiman K. Garge, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Decreased opioid receptor availability and impaired neurometabolic coupling as signatures of morphine tolerance in male rats: A positron emission tomography study
Amélie Soyer, Sarah Leterrier, Sébastien Goutal, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117848-117848
Open Access
Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects
Ross van de Wetering, Loan Y. Vu, Lindsay Kornberger, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 604-604
Open Access
Page 1 - Next Page

Scroll to top